Author: susan

Laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories for the quarter March to May 2026 are presented in this report. Click here to view PDF

This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during June 2026 (epidemiological weeks 23-26). Click here to view PDF

As part of a national laboratory standardisation initiative, our laboratory will migrate from the bromocresol purple (BCP) albumin assay to the bromocresol green (BCG) albumin assay, effective 6 July 2026. Click here to view PDF

From 6 July 2026, PTH will be measured using the Roche Elecsys PTH STAT assay in this laboratory. Click here to view PDF

Worldwide, approximately 250 million people are chronically infected with hepatitis B virus (HBV), with the prevalence in South Africa being approximately 7%. Click here to view PDF

This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during May 2026 (epidemiological weeks 19-22). Click here to view PDF

This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during April 2026 (epidemiological weeks 14-18). Click here to view PDF

This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during March 2026 (epidemiological weeks 10-13). Click here to view PDF

We are proud to announce the expansion of our anticonvulsant therapeutic drug monitoring (TDM) offering to enhance personalized pharmacotherapy. Click here to view PDF

PathCare introduces a new multiplex PCR to detect tick-borne pathogens.  Infective endocarditis (IE) is a globally prevalent condition associated with high morbidity and mortality. Click here to view PDF